Imaging the Ellipsoid Zone as a Biomarker for Clinical Trials for Inherited Retinal Diseases

Time: 9:00 am
day: Conference Day One


  • Ellipsoid zone as a tool to monitor disease progression and patient selection in clinical trials
  • Reviewing OCT biomarkers and adaptive optics and their applications to clinical trials
  • Sharing Phase 1/2 clinical trial data